Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus intermittent letrozole after prior adjuvant endocrine therapy in postmenopausal women with hormone receptor-positive node-positive early breast cancer
2007-001370-88Phase 3Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of letrozole in breast cancer (2 arms), sponsored by International Breast Cancer Study Group. Primary endpoint: Disease-free survival. Started Sep 2007; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-001370-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001370-88.